EUR 2.85
(-2.9%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 25.97 Million CAD | 10.93% |
2022 | 23.41 Million CAD | 37.39% |
2021 | 17.04 Million CAD | 198.88% |
2020 | 5.7 Million CAD | -15.14% |
2019 | 6.71 Million CAD | 94.02% |
2018 | 3.46 Million CAD | -2.24% |
2017 | 3.54 Million CAD | -4.8% |
2016 | 3.72 Million CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 28.11 Million CAD | 10.5% |
2024 Q1 | 25.44 Million CAD | -2.04% |
2024 Q3 | 29.06 Million CAD | 3.39% |
2023 Q3 | 26.62 Million CAD | -2.11% |
2023 Q1 | 24.86 Million CAD | 6.21% |
2023 Q2 | 27.19 Million CAD | 9.37% |
2023 FY | 25.97 Million CAD | 10.93% |
2023 Q4 | 25.97 Million CAD | -2.43% |
2022 FY | 23.41 Million CAD | 37.39% |
2022 Q4 | 23.41 Million CAD | -0.53% |
2022 Q3 | 23.53 Million CAD | 3.33% |
2022 Q2 | 22.78 Million CAD | 5.67% |
2022 Q1 | 21.55 Million CAD | 26.49% |
2021 Q2 | 11.85 Million CAD | 21.89% |
2021 Q4 | 17.04 Million CAD | 13.24% |
2021 Q3 | 15.04 Million CAD | 26.99% |
2021 FY | 17.04 Million CAD | 198.88% |
2021 Q1 | 9.72 Million CAD | 70.52% |
2020 Q1 | 7.08 Million CAD | 5.49% |
2020 Q4 | 5.7 Million CAD | -11.45% |
2020 Q2 | 7.01 Million CAD | -1.02% |
2020 Q3 | 6.43 Million CAD | -8.22% |
2020 FY | 5.7 Million CAD | -15.14% |
2019 FY | 6.71 Million CAD | 94.02% |
2019 Q4 | 6.71 Million CAD | 17.51% |
2019 Q1 | 4.8 Million CAD | 38.77% |
2019 Q3 | 5.71 Million CAD | 36.96% |
2019 Q2 | 4.17 Million CAD | -13.12% |
2018 FY | 3.46 Million CAD | -2.24% |
2018 Q4 | 3.46 Million CAD | -16.79% |
2018 Q1 | - CAD | -100.0% |
2018 Q3 | 4.16 Million CAD | 0.0% |
2017 Q4 | 3.54 Million CAD | 0.0% |
2017 FY | 3.54 Million CAD | -4.8% |
2016 FY | 3.72 Million CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Newron Pharmaceuticals S.p.A. | 1.00 EUR | -2597399900.0% |
Redcare Pharmacy NV | 135.78 Million EUR | 80.871% |